Sort   by:  
 Page size 
The COVID-19 pandemic highlighted the urgent need to develop effective and broad-spectrum antiviral therapies against coronaviruses. One strategy to address this concern is combination therapy using repurposed drugs against zoonotic viruses with pandemic potential. We previously demonstrated that th...
ORGANISM(S): Mus musculus (Mouse) Betacoronavirus 
2026-09-07 | PXD073706 | Pride
OCI AML2 cells were treated with the anti-parasitic ivermectin (single dose, two time points) in order to assess gene expression changes.
ORGANISM(S): Homo sapiens 
Rhipicephalus microplus is among the critical tick parasite of cattle farming globally. However, the massive use of ivermectin last decades induced the generation of the tick-resistant population. Unfortunately, despite extensive research the mode of action of ivermectin remains unclear. Due to the...
ORGANISM(S): Rhipicephalus microplus 
2024-01-29 | PXD031231 | Pride
We have investigated the transcriptomic response of the model nematode Caenorhabditis elegans to ivermectin (IVM); an important anthelmintic for human and animal parasite control. The transcriptomic response of the mutant strain DA1316 avr-14(ad1302); avr-15(ad1250); glc-1(pk54), which is highly res...
ORGANISM(S): Caenorhabditis elegans 
Transcriptomics of Ivermectin Response in Caenorhabditis elegans: integrating Abamectin Quantitative Trait Loci and Comparison to the Ivermectin-Exposed DA1316 Strain
Transcriptomics of Ivermectin Response in Caenorhabditis elegans: integrating Abamectin Quantitative Trait Loci and Comparison to the Ivermectin-Exposed DA1316 Strain
We have investigated the transcriptomic response of the model nematode Caenorhabditis elegans to ivermectin (IVM); an important anthelmintic for human and animal parasite control. The transcriptomic response of the mutant strain DA1316 avr-14(ad1302); avr-15(ad1250); glc-1(pk54), which is highly res...
ORGANISM(S): Caenorhabditis elegans 
2011-04-01 | GSE22660 | GEO
Esophageal squamous cell carcinoma (ESCC) is one of the most common form of malignancies in the world. However, there is currently a lack of effective chemotherapeutic drugs for ESCC, and it is urgent to develop new and safe drugs for this disease. Ivermectin is a broad-spectrum antiparasitic drug w...
ORGANISM(S): Homo sapiens 
2024-12-18 | GSE201404 | GEO
Here, we show that ivermectin suppress prostate cancer progression by inhibiting AR signaling pathway and attenuate cellular DNA damage repair capacity. We applied an integrated omics profiling including RNA-seq and Thermal proteome, that found pioneer factor Forkhead Box Protein A1 (FOXA1) and Non-...
ORGANISM(S): Homo sapiens 
2022-04-01 | GSE169356 | GEO
Sort   by:  
 Page size